BCL2 and colorectal carcinoma: The expression studies suggested that studied regimen effectively reduced the expression of antiapoptotic genes (Bcl-2, K-ras) and increased the tumor suppressor and proapoptotic genes (p53 and Bax) in the CRC rat model.